KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Edwards Lifesciences (EW) Invested Capital (2016 - 2025)

Historic Invested Capital for Edwards Lifesciences (EW) over the last 17 years, with Q3 2025 value amounting to $10.2 billion.

  • Edwards Lifesciences' Invested Capital rose 617.6% to $10.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $10.2 billion, marking a year-over-year increase of 617.6%. This contributed to the annual value of $10.7 billion for FY2024, which is 4570.83% up from last year.
  • Per Edwards Lifesciences' latest filing, its Invested Capital stood at $10.2 billion for Q3 2025, which was up 617.6% from $10.6 billion recorded in Q2 2025.
  • Over the past 5 years, Edwards Lifesciences' Invested Capital peaked at $10.7 billion during Q4 2024, and registered a low of $4.7 billion during Q1 2021.
  • Its 5-year average for Invested Capital is $7.3 billion, with a median of $6.4 billion in 2023.
  • Per our database at Business Quant, Edwards Lifesciences' Invested Capital crashed by 44.47% in 2022 and then skyrocketed by 4570.83% in 2024.
  • Over the past 5 years, Edwards Lifesciences' Invested Capital (Quarter) stood at $6.4 billion in 2021, then dropped by 0.44% to $6.4 billion in 2022, then grew by 14.27% to $7.3 billion in 2023, then skyrocketed by 45.71% to $10.7 billion in 2024, then decreased by 4.27% to $10.2 billion in 2025.
  • Its Invested Capital was $10.2 billion in Q3 2025, compared to $10.6 billion in Q2 2025 and $10.2 billion in Q1 2025.